Commencement of UK sales

RNS Number : 4685I
Highlands Natural Resources PLC
09 August 2019
 

9 August 2019

 

Highlands Natural Resources plc

("Highlands" or the "Company")

 

Commencement of UK sales

 

Highlands, the London listed natural resources company, is pleased to announce that Zoetic, its wholly owned, vertically integrated CBD subsidiary, has commenced sales in the UK via its website www.zoetic.uk.com.

 

The first product lines in the UK will be CBD tinctures. These are available in four flavours (natural, peppermint, melon and blood orange) and two strengths (500mg and 1,000mg). In the coming months, Zoetic will expand its UK product range. At present, online sales are limited to UK customers but Zoetic intends to shortly offer its products to other European countries.

 

In the US, Zoetic and Chill products are now available on LeafyQuick and in 36 convenience stores. Zoetic's range in the US includes both CBD tinctures and soft gels, and Chill's range includes smokables and vapes.

 

Until the end of August, Zoetic is offering a 20% discount to UK customers who join its mailing list on www.zoetic.uk.com.

 

**ENDS**

 

Enquiries

 

Highlands Natural Resources plc                                                                                                                     

Robert Price                                                                                                                        +1 (0) 303 322 1066

Nick Tulloch                                                                                                                       +44 (0) 1738 472 029

 

Cantor Fitzgerald Europe                                                                                                +44 (0) 20 7894 7000        

David Porter      

                               

Newgate Communications                                                                                             +44 (0) 20 3757 6880

Elisabeth Cowell

Ian Silvera          

Fiona Norman  

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCLLFVETAITIIA
UK 100

Latest directors dealings